Pharmacokinetics of the enantiomers of bupivacaine and mepivacaine after epidural administration of the racemates

Anesthesia and Analgesia

Volumn 86, Issue 2, 1998, Pages 361-366

  Groen, Kees ^a   Mantel, Marijke ^a   Zeijlmans, Peter W M ^a   Zeppenfeldt, Bas ^b   Olieman, Wim ^b   Stienstra, Rudolf ^b   Van Kleef, Jack W ^b   Burm, Anton G L ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG PROTEIN BINDING; ENANTIOMER; EPIDURAL ANESTHESIA; EPIDURAL DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; RACEMIC MIXTURE; SURGICAL PATIENT;

ADULT; AREA UNDER CURVE; BUPIVACAINE; HUMANS; INJECTIONS, EPIDURAL; INJECTIONS, INTRAVENOUS; MEPIVACAINE; MIDDLE AGED; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031937088     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199802000-00027     Document Type: Article

References (25)

1. Cahn RS, Ingold CK, Prelog V. The specification of asymmetric configuration in organic chemistry. Experientia 1956;12:81-94.
2. Burm AGL, Van der Meer AD, Van Kleef JW, et al. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate. Br J Clin Pharmacol 1994; 38:125-9.
3. Burm AGL, Cohen IMC, Van Kleef JW, et al. Pharmacokinetics of the enantiomers of mepivacaine following intravenous administration of the racemate in volunteers. Anesth Analg 1997; 84:85-9.
4. Berrisford RG, Sabanathan S, Mearns AJ, et al. Plasma concentrations of bupivacaine and its enantiomers during continuous extrapleural intercostal nerve block. Br J Anaesth 1993;70:201-4.
5. Mather LE, McCall P, McNicol PL. Bupivacaine enantiomer pharmacokinetics after intercostal neural blockade in liver transplantation patients. Anesth Analg 1995;80:328-35.
6. Vree TB, Beumer EMC, Lagerwerf AJ, et al. Clinical pharmacokinetics of R(+)-mepivacaine and S(-)-mepivacaine after high doses of racemic mepivacaine with epinephrine in the combined psoas compartment/sciatic nerve block. Anesth Analg 1992;75: 75-80.
7. Veering BT, Burm AGL, Gladines MPRR, Spierdijk J. Age does not influence the serum protein binding of bupivacaine. Br J Clin Pharmacol 1991;32:501-3.
8. Groen K, Zeijlmans PWM, Burm AGL, Van Kleef JW. Improved clean-up procedure for the high-performance liquid chromatographic assay of bupivacaine enantiomers in human plasma and ultrafiltrate in the nanogram per milliliter range. J Chromatogr B Biomed Appl 1994;655:163-6.
9. Vletter AA, Olieman W, Burm AGL, et al. High-performance liquid chromatographic assay of mepivacaine enantiomers in human plasma in the nanogram per milliliter range. J Chromatogr B Biomed Appl 1996;678:369-72.
10. Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet Biopharm 1980;9:509-34.
11. Benet LZ, Galeazzi RL. Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 1979;68:1071-4.
12. Perrier D, Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. J Pharm Sci 1982;71:372-3.
13. Åberg G. Toxicological and local anaesthetic effects of optically active isomers of two local anaesthetic compounds. Acta Pharmacol Toxicol (Copenh) 1972;31:273-86.
14. Luduena FP, Bogado EF, Tullar BF. Optical isomers of mepivacaine and bupivacaine. Arch Int Pharmacodyn Ther 1972;200: 359-69.
15. Aps C, Reynolds F. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. Br J Clin Pharmacol 1978;6:63-8.
16. Fairley JW, Reynolds F. An intradermal study of the local anaesthetic and vascular effects of the isomers of mepivacaine. Br J Anaesth 1981;53:1211-6.
17. Mather LE. Disposition of mepivacaine and bupivacaine enantiomers in sheep. Br J Anaesth 1991;67:239-46.
18. Rutten AJ, Mather LE, McLean CF. Cardiovascular effects and regional clearances of i.v. bupivacaine in sheep: enantiomeric analysis. Br J Anaesth 1991;67:247-56.
19. Vanhoutte F, Vereecke J, Verbeke N, Carmeliet E. Stereoselective effects of the enantiomers of bupivacaine on the electrophysiological properties of the guinea-pig papillary muscle. Br J Pharmacol 1991;103:1275-81.
20. Denson DD, Behbehani MM, Gregg RV. Enantiomer-specific effects of an intravenously administered arrhythmogenic dose of bupivacaine on neurons of the nucleus tractus solitarius and the cardiovascular system in the anesthetized rat. Reg Anesth 1992;17:311-6.
21. Mazoit JX, Boïco O, Samii K. Myocardial uptake of bupivacaine. II. Pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993;77:477-82.
22. Lee-Son S, Wang GK, Concus A, et al. Stereoselective inhibition of neuronal sodium channels by local anesthetics. Anesthesiology 1992;77:324-35.
23. Burm AGL, Vermeulen NPE, Van Kleef JW, et al. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration: simultaneous investigation of absorption and disposition kinetics using stable isotopes. Clin Pharmacokinet 1987;13:191-203.
24. Faccenda KA, Cox C, Gilhooly C, et al. Extradural levobupivacaine: a comparison with racemic bupivacaine. Reg Anesth 1997;22(Suppl 2S):64.
25. Gristwood R, Bardsley H, Baker H, Dickens J. Reduced cardiotoxicity of levobupivacaine compared with racemic bupivacaine (Marcaine): new clinical evidence. Exp Opin Invest Drugs 1994; 3:1209-12.